J&J hip recall: Internal emails detail FDA’s non-approvable letter

 
J&J hip recall: Internal emails detail FDA's non-approvable letter (MassDevice)
Uncovered internal emails from Johnson & Johnson subsidiary DePuy Orthopaedics highlight the company's decisions to abandon a PMA bid for the now-defunct ASR hip resurfacing implants amid "a significant number of revisions" during clinical trials.
A newly uncovered Johnson & Johnson email may pose problems for the health care giant in the ongoing lawsuits over defunct hip implants made by subsidiary DePuy Orthopaedics.
DePuy has insisted that the recalled ASR metal-on-metal hip resurfacing implan...